Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-03

FDA Approved: BREXPIPRAZOLE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA Inc.'s original application for brexpiprazole (brexpiprazole), authorizing a generic version of the antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • brexpiprazole (brexpiprazole)

Snippet

ORIG AP for BREXPIPRAZOLE (BREXPIPRAZOLE)